My Quote Request
No products added yet
6505-01-238-6191
20 Products
NDC00172-2184-80
QUININE SULFATE CAPSULES,USP
NSN, MFG P/N
6505012386191
NSN
6505-01-238-6191
NDC00172-2184-80
QUININE SULFATE CAPSULES,USP
NSN, MFG P/N
6505012386191
NSN
6505-01-238-6191
MFG
ZENITH LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS QUININE SULFATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
2184
QUININE SULFATE CAPSULES,USP
NSN, MFG P/N
6505012386191
NSN
6505-01-238-6191
MFG
ZENITH LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS QUININE SULFATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00071-0443-30
CLONIDINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012386192
NSN
6505-01-238-6192
NDC00071-0443-30
CLONIDINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012386192
NSN
6505-01-238-6192
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 MILLIGRAMS CLONIDINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00182-1767-05
CLONIDINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012386192
NSN
6505-01-238-6192
NDC00182-1767-05
CLONIDINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012386192
NSN
6505-01-238-6192
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 MILLIGRAMS CLONIDINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
RS-202
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505012386194
NSN
6505-01-238-6194
RS-202
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505012386194
NSN
6505-01-238-6194
MFG
MINNTECH CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 101.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 2.500 GRAMS DEXTROSE PER LITER AND 134.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 37.000 MILLIEQUIVALENTS ACETATE ION PER LITER AND 1.500
PRIMARY CONTAINER CONTENT QUANTITY: 3430.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART SOLUTION WITH 34 PARTS WATER
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: MILLIEQUIVALENTS MAGNESIUM ION PER LITER
Related Searches:
DEVROM
BISMUTH SUBGALLATE TABLETS
NSN, MFG P/N
6505012386629
NSN
6505-01-238-6629
MFG
PARTHENON CO INC THE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS BISMUTH SUBGALLATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL, CHEWABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BISMUTH SUBGALLATE TABLETS 200MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: DEODORANT FOR COLOSTOMY OR ILEOSTOMY
DEVROM P1963
BISMUTH SUBGALLATE TABLETS
NSN, MFG P/N
6505012386629
NSN
6505-01-238-6629
DEVROM P1963
BISMUTH SUBGALLATE TABLETS
NSN, MFG P/N
6505012386629
NSN
6505-01-238-6629
MFG
PARTHENON CO INC THE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS BISMUTH SUBGALLATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL, CHEWABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BISMUTH SUBGALLATE TABLETS 200MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: DEODORANT FOR COLOSTOMY OR ILEOSTOMY
DEVROM-TABLETS
BISMUTH SUBGALLATE TABLETS
NSN, MFG P/N
6505012386629
NSN
6505-01-238-6629
DEVROM-TABLETS
BISMUTH SUBGALLATE TABLETS
NSN, MFG P/N
6505012386629
NSN
6505-01-238-6629
MFG
PARTHENON CO INC THE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS BISMUTH SUBGALLATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL, CHEWABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BISMUTH SUBGALLATE TABLETS 200MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: DEODORANT FOR COLOSTOMY OR ILEOSTOMY
2B4403
HEPARIN SODIUM INJECTION,USP AND DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012388082
NSN
6505-01-238-8082
2B4403
HEPARIN SODIUM INJECTION,USP AND DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012388082
NSN
6505-01-238-8082
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20000.000 USP UNITS HEPARIN EQUIVALENT
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
SPECIAL FEATURES: 40 USP UNITS HEPARIN PER ML; 5 PCT W/V DEXTROSE; SINGLE DOSE; DUAL CHAMBERED FLEXIBLE PLASTIC BAG; HEPARIN SODIUM IN UPPER CHAMBER,DEXTROSE IN LOWER CHAMBER; W/OUTLET PORT; IN OVERPOUCH; FOR USE WITH DOD STOCKLISTED IV ADMINISTRATION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00338-0449-03
HEPARIN SODIUM INJECTION,USP AND DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012388082
NSN
6505-01-238-8082
NDC00338-0449-03
HEPARIN SODIUM INJECTION,USP AND DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012388082
NSN
6505-01-238-8082
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20000.000 USP UNITS HEPARIN EQUIVALENT
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
SPECIAL FEATURES: 40 USP UNITS HEPARIN PER ML; 5 PCT W/V DEXTROSE; SINGLE DOSE; DUAL CHAMBERED FLEXIBLE PLASTIC BAG; HEPARIN SODIUM IN UPPER CHAMBER,DEXTROSE IN LOWER CHAMBER; W/OUTLET PORT; IN OVERPOUCH; FOR USE WITH DOD STOCKLISTED IV ADMINISTRATION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
63824-0008-10
GUAIFENESIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012389443
NSN
6505-01-238-9443
63824-0008-10
GUAIFENESIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012389443
NSN
6505-01-238-9443
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 600.000 MILLIGRAMS GUAIFENESIN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GUAIFENESIN EXTENDED RELEASE TABLETS 600MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SUSTAINED ACTING FOR 12 HRS AFTER ADMINISTRATION,W/THE FOLLOWING RELEASE RATES: 15-35% W/I 1 HR; 30-55% W/I 2 HRS; 45-75% W/I 4 HRS; 70-95% W/I 8 HRS; NOT LATER THAN 80% W/I 10 HRS
SUPPLEMENTARY FEATURES: USE PREFERRED NSN, 6505-01-539-3176 IN ACCORDANCE WITH THE JDF
Related Searches:
ADAMS LABS
GUAIFENESIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012389443
NSN
6505-01-238-9443
ADAMS LABS
GUAIFENESIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012389443
NSN
6505-01-238-9443
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 600.000 MILLIGRAMS GUAIFENESIN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GUAIFENESIN EXTENDED RELEASE TABLETS 600MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SUSTAINED ACTING FOR 12 HRS AFTER ADMINISTRATION,W/THE FOLLOWING RELEASE RATES: 15-35% W/I 1 HR; 30-55% W/I 2 HRS; 45-75% W/I 4 HRS; 70-95% W/I 8 HRS; NOT LATER THAN 80% W/I 10 HRS
SUPPLEMENTARY FEATURES: USE PREFERRED NSN, 6505-01-539-3176 IN ACCORDANCE WITH THE JDF
Related Searches:
MUCINEX
GUAIFENESIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012389443
NSN
6505-01-238-9443
MUCINEX
GUAIFENESIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012389443
NSN
6505-01-238-9443
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 600.000 MILLIGRAMS GUAIFENESIN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GUAIFENESIN EXTENDED RELEASE TABLETS 600MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SUSTAINED ACTING FOR 12 HRS AFTER ADMINISTRATION,W/THE FOLLOWING RELEASE RATES: 15-35% W/I 1 HR; 30-55% W/I 2 HRS; 45-75% W/I 4 HRS; 70-95% W/I 8 HRS; NOT LATER THAN 80% W/I 10 HRS
SUPPLEMENTARY FEATURES: USE PREFERRED NSN, 6505-01-539-3176 IN ACCORDANCE WITH THE JDF
Related Searches:
NDC53824-0008-10
GUAIFENESIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012389443
NSN
6505-01-238-9443
NDC53824-0008-10
GUAIFENESIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012389443
NSN
6505-01-238-9443
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 600.000 MILLIGRAMS GUAIFENESIN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GUAIFENESIN EXTENDED RELEASE TABLETS 600MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SUSTAINED ACTING FOR 12 HRS AFTER ADMINISTRATION,W/THE FOLLOWING RELEASE RATES: 15-35% W/I 1 HR; 30-55% W/I 2 HRS; 45-75% W/I 4 HRS; 70-95% W/I 8 HRS; NOT LATER THAN 80% W/I 10 HRS
SUPPLEMENTARY FEATURES: USE PREFERRED NSN, 6505-01-539-3176 IN ACCORDANCE WITH THE JDF
Related Searches:
APHRODYNE
YOHIMBINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505012389445
NSN
6505-01-238-9445
APHRODYNE
YOHIMBINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505012389445
NSN
6505-01-238-9445
MFG
STAR PHARMACEUTICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.400 MILLIGRAMS YOHIMBINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: YOHIMBINE HYDROCHLORIDE TABLETS 5.4 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
APHRODYNE TABLETS
YOHIMBINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505012389445
NSN
6505-01-238-9445
APHRODYNE TABLETS
YOHIMBINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505012389445
NSN
6505-01-238-9445
MFG
STAR PHARMACEUTICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.400 MILLIGRAMS YOHIMBINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: YOHIMBINE HYDROCHLORIDE TABLETS 5.4 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
NDC00076-0401-03
YOHIMBINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505012389445
NSN
6505-01-238-9445
NDC00076-0401-03
YOHIMBINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505012389445
NSN
6505-01-238-9445
MFG
STAR PHARMACEUTICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.400 MILLIGRAMS YOHIMBINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: YOHIMBINE HYDROCHLORIDE TABLETS 5.4 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC52152-0032-02
YOHIMBINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505012389445
NSN
6505-01-238-9445
NDC52152-0032-02
YOHIMBINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505012389445
NSN
6505-01-238-9445
MFG
AMIDE PHARMACEUTICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.400 MILLIGRAMS YOHIMBINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: YOHIMBINE HYDROCHLORIDE TABLETS 5.4 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC53159-0001-01
YOHIMBINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505012389445
NSN
6505-01-238-9445
NDC53159-0001-01
YOHIMBINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505012389445
NSN
6505-01-238-9445
MFG
PALISADES PHARMACEUTICALS INC P O BOX 1508 S HACKENSACK NJ 07606
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.400 MILLIGRAMS YOHIMBINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: YOHIMBINE HYDROCHLORIDE TABLETS 5.4 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
YOCON
YOHIMBINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505012389445
NSN
6505-01-238-9445
YOCON
YOHIMBINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505012389445
NSN
6505-01-238-9445
MFG
PALISADES PHARMACEUTICALS INC P O BOX 1508 S HACKENSACK NJ 07606
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.400 MILLIGRAMS YOHIMBINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: YOHIMBINE HYDROCHLORIDE TABLETS 5.4 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
